The study was performed at the Veterinary Medical Center of the University of Tokyo. The study was presented at 29th Annual Conference of Veterinary Cancer Society in 2009.
Increase in Minimal Residual Disease in Peripheral Blood before Clinical Relapse in Dogs with Lymphoma that Achieved Complete Remission after Chemotherapy
Version of Record online: 11 FEB 2011
Copyright © 2011 by the American College of Veterinary Internal Medicine
Journal of Veterinary Internal Medicine
Volume 25, Issue 2, pages 292–296, March/April 2011
How to Cite
Sato, M., Yamazaki, J., Goto-Koshino, Y., Takahashi, M., Fujino, Y., Ohno, K. and Tsujimoto, H. (2011), Increase in Minimal Residual Disease in Peripheral Blood before Clinical Relapse in Dogs with Lymphoma that Achieved Complete Remission after Chemotherapy. Journal of Veterinary Internal Medicine, 25: 292–296. doi: 10.1111/j.1939-1676.2010.0675.x
- Issue online: 7 MAR 2011
- Version of Record online: 11 FEB 2011
- Submitted August 26, 2010; Revised November 24, 2010; Accepted December 13, 2010.
- 4Chemotherapy of canine lymphoma with histopathological correlation: Doxorubicine alone compared to COP as first treatment regimen. J Am Anim Hosp Assoc 1987;23:587–596., , , et al.
- 6MOPP chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989–2000). J Vet Intern Med 2002;16:576–580., , , et al.
- 16Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction. Leuk Res 2003;27:925–934., , , et al.
- 24TNM Classification of Tumours in Domestic Animals. Geneva: World Health Organization; 1980:46–47.